First Tracks Biotherapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10770 Wateridge Cir Ste 210, San Diego, ...Website
www.firsttracksbio.comRevenue
-Industry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About First Tracks Biotherapeutics
First Tracks Bio is a biotechnology company focused on developing antibody-based therapies for autoimmune and inflammatory diseases. The company advances immunology treatments designed to modulate immune pathways and improve outcomes for patients with chronic immune-related conditions. It aims to translate scientific research into targeted therapies that address unmet medical needs.Explore more
Popular SearchesFirst Tracks Biotherapeutics IncSIC Code 87,873NAICS Code 54,541Show moreFirst Tracks Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is First Tracks Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at First Tracks Biotherapeutics
Click to see if First Tracks Biotherapeutics had a recent Job posting/layoffs
Check out if First Tracks Biotherapeutics is spiking on competitors!
Check if First Tracks Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on First Tracks Biotherapeutics recently announced quarterly report
Product Launch: Get notified when First Tracks Biotherapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
First Tracks Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once First Tracks Biotherapeutics has new funding data
Recommended Actions
Find VP level buyers at First Tracks Biotherapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
First Tracks Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
First Tracks Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about First Tracks Biotherapeutics.
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
First Tracks Biotherapeutics News & Media
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
SAN DIEGO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today reported financial results for the second quarter ended June 30, 2026, and provided a business update.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding First Tracks Biotherapeutics
Sign Up For FreeTo access detailed company insights
First Tracks Bio is a biotechnology company focused on developing antibody-based therapies for autoimmune and inflammatory diseases. The company advances immunology treatments designed to modulate immune pathways and improve outcomes for patients with chronic immune-related conditions. It aims to translate scientific research into targeted therapie... Read More
